MktsMarkets

Anixa Biosciences, Inc.
NASDAQ: ANIXKey statistics
ANIX News
Stories mentioning ANIX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q2 '26Apr 30 | Q1 '26Jan 31 | Q4 '25Oct 31 | Q3 '25Jul 31 | Q2 '25Apr 30 | Q1 '25Jan 31 | Q4 '24Oct 31 | Q3 '24Jul 31 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | ||||||||
| Research & Development | 1,258 | 1,102 | 1,142 | 1,055 | 1,322 | 1,552 | 1,476 | 1,925 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | (2,647) | (2,716) | (2,876) | (2,436) | (3,003) | (3,386) | (3,163) | (3,592) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (2,516) | (2,565) | (2,695) | (2,258) | (2,790) | (3,184) | (2,883) | (3,277) |
| Earnings Per Share (Basic) | (0.07) | (0.08) | (84.22) | (0.07) | (0.09) | (0.10) | (90.09) | (0.10) |
| Earnings Per Share (Diluted) | (0.07) | (0.08) | (84.22) | (0.07) | (0.09) | (0.10) | (90.09) | (0.10) |
| Weighted Average Shares Outstanding (Basic) | 33,593 | 33,240 | 32.00 | 32,476 | 32,202 | 32,197 | 32.00 | 32,054 |
| Weighted Average Shares Outstanding (Diluted) | 33,593 | 33,240 | 32.00 | 32,476 | 32,202 | 32,197 | 32.00 | 32,054 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About ANIX
Anixa Biosciences, Inc. (NASDAQ: ANIX) is a stock listed on the Nasdaq Stock Market under the ticker symbol ANIX. It last traded at $2.99 (Oct 23, 2026, 4:00 PM ET), up 7.5% on the day. That gives Anixa Biosciences a market capitalisation of $103.9M.
Over the past 52 weeks ANIX has traded between $2.32 and $5.46.
For the quarter ended Apr 30, 2026 it reported a net loss of $2.5M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Apr 30, 2026 | — | -$2.5M |
| Jan 31, 2026 | — | -$2.6M |
| Oct 31, 2025 | — | -$2.7M |
| Jul 31, 2025 | — | -$2.3M |
From Anixa Biosciences’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…